Abstract
Provisional stenting is associated with longer physician time but the use of fewer stents. This randomized controlled trial in tertiary care in French hospitals compared strategies of systematic and provisional stenting. We estimated the costs and financial incentives associated with each strategy, based on individual data on 12-month resource use drawn from a 251-patient database.Resources were evaluated using French costs; data on costs in the United States were drawn from the literature and interviews with hospital administrators in one center. In France 1-year costs were $8,267±528 for provisional stenting and $7,973±553 for systematic stenting, compared to $18,715 and $18,632 in the United States. Given the uncertainty of longterm results, the choice between stenting strategies might be guided by financial incentives. In the United States financial incentives favor systematic stenting, while in France public hospitals and physicians are neutral.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Isabelle Durand-Zaleski Santé Publique, Hôpital Henri Mondor,51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France, e-mail: isabelle.durand-zaleski@.ap-hop-paris.fr
Rights and permissions
About this article
Cite this article
Durand-Zaleski, I., Dupouy, P., Coste Carrié, D. et al. A tale of two countries: costs and financial incentives for provisional stenting during percutaneous coronary intervention in France and the United States. Eur J Health Econom 3, 235–239 (2002). https://doi.org/10.1007/s10198-002-0130-9
Issue Date:
DOI: https://doi.org/10.1007/s10198-002-0130-9